Q32 Bio Inc Share Price Today: Live Updates & Key Insights

Q32 Bio Inc share price today is $6.68, up 0.15%. The stock opened at $6.84 against the previous close of $6.67, with an intraday high of $6.92 and low of $6.16.

Q32 Bio Inc Share Price Chart

Q32 Bio Inc

us-stock
To Invest in {{usstockname}}
us-stock

Q32 Bio Inc Share Price Performance

$6.68 0.0015(0.15%) QTTB at 23 Mar 2026 02:57 PM Biotechnology
Lowest Today 6.16
Highest Today 6.92
Today’s Open 6.84
Prev. Close 6.67
52 Week High 7.80
52 Week Low 1.35
Day’s Range: Low 6.16 High 6.92
52-Week Range: Low 1.35 High 7.80
1 day return -
1 Week return +5.38
1 month return +45.19
3 month return +114.51
6 month return +253.72
1 year return +205.04
3 year return -61.51
5 year return -96.52
10 year return -

Q32 Bio Inc Institutional Holdings

Q32 Bio Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 2

Sell: 0

Strong Sell: 0

Q32 Bio Inc Fundamentals

Market Cap 97.72 M

PB Ratio 2.3225

PE Ratio 2.7603

Enterprise Value 64.63 M

Total Assets 61.78 M

Volume 384514

Q32 Bio Inc Company Financials

Annual Revenue FY23:1156000 1.2M

Annual Profit FY23:578000 0.6M

Annual Net worth FY23:-112961000 -113.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-91000 -0.1M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-121000 -0.1M

Quarterly Net worth Q3/2025:-7389000 -7.4M, Q2/2025:-9489000 -9.5M, Q1/2025:-11031000 -11.0M, Q3/2024:-17595000 -17.6M, Q2/2024:-16978000 -17.0M

About Q32 Bio Inc & investment objective

Company Information Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

Organisation Biotechnology

Employees 24

Industry Biotechnology

CEO Ms. Jodie Pope Morrison

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Q32 Bio Inc FAQs

What is the share price of Q32 Bio Inc today?

The current share price of Q32 Bio Inc is $6.68.

Can I buy Q32 Bio Inc shares in India?

Yes, Indian investors can buy Q32 Bio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Q32 Bio Inc shares in India?

You can easily invest in Q32 Bio Inc shares from India by:

Can I buy fractional shares of Q32 Bio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Q32 Bio Inc?

Q32 Bio Inc has a market cap of $97.72 M.

In which sector does Q32 Bio Inc belong?

Q32 Bio Inc operates in the Biotechnology sector.

What documents are required to invest in Q32 Bio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Q32 Bio Inc?

The PE ratio of Q32 Bio Inc is 2.76 and the PB ratio is 2.32.